Drug Information Association Logo
Corporate Tagline

Session 4A: Drug Development in Latin America

Day & Time:
October 22, 3:30PM - 5:00PM


Session 4A: Drug Development in Latin America

João Massud Filho, MD
Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil

Charles Schmidt, MD
Head Scientific Medical Advisory Board, Prof., Santa Casa Medical School
Esterm Medical CRO, Brazil

Since the drug development is even more global it is necessary to explore the possibilities to do it in Latin America. It is expected that after this session the attendees will have a more clear comprehension on how to be engaged on it.

Presentation(s) & Speaker(s):
Preclinical Studies
João Batista Calixto, MD
Federal University of Santa Catarina, Brazil

Drug Development in Argentina - An Example
Fernando Goldbaum, MD,PhD
Principal Investigator
Leloir Institute, Argentina

Business and Scientific Opportunities for Drug Development in Latin America
Clarice Tobias De Aguiar Moeller Sztajnbok
Vice President, Medical Affairs
Sanofi, Brazil